This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Respiratory Muscle Strength in Patients With NMD (RMST)

This study is currently recruiting participants.
See Contacts and Locations
Verified April 2017 by University of Florida
Sponsor:
Information provided by (Responsible Party):
University of Florida
ClinicalTrials.gov Identifier:
NCT01555905
First received: March 14, 2012
Last updated: April 4, 2017
Last verified: April 2017
March 14, 2012
April 4, 2017
April 2011
June 2020   (Final data collection date for primary outcome measure)
Maximal respiratory pressure [ Time Frame: 3 months ]
The primary endpoints for inspiratory muscle training efficacy will be maximal respiratory pressure tests, a measure of respiratory strength.
VT/FVC [ Time Frame: 3 months ]
The primary endpoints for inspiratory muscle training efficacy will include respiratory muscle strength.
Complete list of historical versions of study NCT01555905 on ClinicalTrials.gov Archive Site
Peak flow volumes during loaded breaths [ Time Frame: 3 months ]
Secondary outcome measures include respiratory function and breathing pattern during loaded breathing against standard resistances.
VT/FVC [ Time Frame: 3 months ]
Secondary outcome measures include respiratory function and breathing pattern during loaded breathing
Not Provided
Not Provided
 
Respiratory Muscle Strength in Patients With NMD
Respiratory Muscle Strength and Function in Patients With Neuromuscular Disease
The purpose of this study is to determine if inspiratory muscle strength training (IMST) will impact maximal inspiratory pressure and pulmonary function in patients with neuromuscular disease.
Subjects undergo a 12-week period of inspiratory muscle strength training. Respiratory strength is assessed before and after the training period.
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Neuromuscular Disease
Device: Threshold PEP or IMT device Phillips-Respironics
The subject will be instructed to take 8-15 deep, forceful breaths through the Threshold device, followed by at least 3 minutes of rest. The process will be repeated 3 more times for a total of 4 sets of 8-15 breaths. IMST will be completed three to five days per week, based upon the subject's daily baseline level of fatigue.
Experimental: Exercise
Threshold PEP or IMT device Phillips-Respironics
Intervention: Device: Threshold PEP or IMT device Phillips-Respironics
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
30
December 2020
June 2020   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Confirmed diagnosis of neuromuscular disease
  • Clinical evidence of impaired pulmonary function

Exclusion Criteria:

  • Above or below age range
  • No clinical evidence of impaired pulmonary function
  • No diagnosis of a neuromusuclar disease
  • Presence of an acute illness at time of study
  • Participating in other research studies involving investigational drugs
  • Diagnosis of a primary pulmonary disease
  • Use of tobacco products
Sexes Eligible for Study: All
6 Months to 65 Years   (Child, Adult)
No
United States
 
 
NCT01555905
UF-IRB 201600270
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Plan to Share IPD: No
University of Florida
University of Florida
Not Provided
Principal Investigator: Barbara K Smith, PhD, PT University of Florida
University of Florida
April 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP